Determination of regional coronary flow utilizing microspheres in ex vivo myocardial ischemia/reperfusion (MI/R) injury
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Results

Following an acute myocardial infarction, reperfusion of blood flow to the
ischemic myocardium, although necessary, leads to compromised heart
function resulting in MI/R injury. PKC epsilon positively regulates eNOS
activity. During I/R, PKC epsilon peptide inhibitor (PKCε-) inhibits uncoupled
eNOS activity and attenuates mitochondrial damage to reduce superoxide
and inhibits the induction of the inflammatory response (Fig. 1) [1, 2]. To
further evaluate the cardioprotective effects of PKCε- in MI/R injury, we
assessed regional blood flow by measuring regional microsphere
fluorescence density after injecting fluorescent microspheres into isolated
perfused rat hearts subjected to I (30 min)/ R (45 min) with/without PKCε-
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We hypothesize that PKC ε- treated I/R hearts compared to untreated I/R
hearts will exhibit improved post-reperfused cardiac function and regional
coronary flow.
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Figure 2. Flow diagram of an experimental protocol

Tissue Digestion & Microsphere Extraction:

Tissue Digestion &
Microsphere Extraction

Microspheres were dissolved in
2-ethoxyethyl acetate and 100 μL samples were
Microsphere
plated in 96 well round bottom black
polypropylene plates [6]. Fluorescence intensity Fluorescence Detection
was measured with a HORIBA FluoroMax Series
spectrofluorometer.
Statistical Analysis: All data in the figures are presented as means ± S.E.M.
A student’s t-test was used to assess statistical difference in cardiac
functions and microsphere fluorescence between I/R and I/R + PKCεhearts. Probability values of < 0.05 were considered statistically significant.
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Figure 4. Comparison of ratio of fluorescence per gram tissue weight between
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protocol represented in Fig. 2.
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Microsphere Injections: Polystyrene Microspheres (FluoSpheres, (mmHg/sec)
ThermoFisher Scientific), Kit #4, 15 μm diameter, 1.0 X 106 beads/ml, were
Final
used to evaluate regional coronary flow [5]. Fifteen µL of a stock microsphere
solution was diluted with 1,485 µL of 37°C Krebs’ buffer to a final volume of +dP/dtmax 2294.1 ± 117.6 1786.7 ± 201.4
1.5 mL of microsphere injection solution. One mL microspheres manually (mmHg/sec)
injected into the heart via retrograde perfusion at a rate of 1mL/minute for a
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total of approximately 10,000 microspheres per injection.
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Figure 1. Schematic representation of PKCε regulation of mitochondrial and uncoupled
eNOS superoxide (O2-) release in myocardial I/R (left) and mechanism of action of PKCε(right; adapted [3]). I/R insult activates PKC (e.g., PKCε) and causes overproduction of O2mainly from damaged mitochondria. The oxidative stress leads to eNOS uncoupling which
produces O2- instead of NO resulting in vascular endothelial dysfunction. Activated PKCε
enhances eNOS activity and opens mitochondrial ATP-dependent potassium channels
causing exacerbation of I/R injury during reperfusion. By contrast, PKCε- inhibits PKCε
translocation to interact with both substrates by binding to the PKCε receptor for activated
C kinase (RACK) domain (see right panel) to provide cardioprotective effects.
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Microsphere fluorescence is theorized to be representative of coronary
regional flow. Data in figure 4. show a ratio of the microsphere
fluorescence per gram tissue weight between PKCε- treated I/R hearts and
Untreated sham (i.e., no I/R) hearts without microsphere maintained cardiac contractile function throughout the experimental time period. By contrast, sham
untreated I/R hearts in right ventricle, septum, and left ventricle. PKCεhearts that received triple microsphere injections showed a significant decrease in left ventricular developed pressure (LVDP) (i.e., left ventricular end-systolic
treated I/R hearts showed an increase in mean fluorescence by almost twopressure (LVESP) minus left ventricular end-diastolic pressure [LVEDP]) and this effect is attributed to a significant decrease in LVESP and - dpdt min (Fig. 3).
fold in the left ventricle at 45 minutes of reperfusion. Whereas the right
For LVDP percent recovery of baseline:
ventricle and septum show equivalent mean fluorescence compared to the
• Untreated I/R hearts recovered to 48 ± 5%
• PKCε- treated I/R hearts recovered to 83 ± 6%
left ventricle at 45 min reperfusion.
• Untreated I/R hearts with triple microsphere injections recovered to 30 ± 6%
• PKCε- treated I/R hearts with triple microsphere injections recovered to 70± 8%
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PKCε- treated I/R hearts (n=8) and untreated I/R (n=7) hearts in right ventricle,
septum, and left ventricle in triple microsphere injected hearts.

Conclusions
As expected, PKCε- treated I/R hearts showed significant improvement in
almost all final cardiac function parameters (LVDP, LVESP, etc.) regardless
of exposure to single or triple microsphere injections. Under all
conditions, PKCε- treated I/R hearts exhibited improved coronary flow in
the left ventricle and this improvement in flow probably underlies the
improvement in cardiac performance.
Determination of regional coronary flow using microspheres allows for a
direct correlation between left ventricular coronary flow and left
ventricular cardiac function. As evidenced by the data in Fig. 3, coronary
flow between PKCε- treated I/R hearts (n=8) and I/R hearts (n=7) were
equivalent, yet regional flow in the left ventricle measured by
microspheres was significantly increased in PKCε- treated I/R hearts, see
Fig. 4. Our findings suggest that the ex vivo rat heart is sensitive to
reductions in oxygen concentration in Krebs’ buffer. Such that detectable
levels of microspheres induce measurable depression of cardiac function.
Future experiments will determine the fluorescence in the single injection
45 min reperfusion experiments.
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